Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy

Clinical trial NCT05902247 · UNKNOWN

Trial details

NCT number: NCT05902247
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2021-12-29
Primary completion: 2025-12-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.